Clinical Report: Erratum on TSHR Signaling and PTEN/PI3K in Thyroid Cancer
Background
Dysregulated signaling pathways, such as TSHR and PTEN/PI3K, play significant roles in the progression and dedifferentiation of thyroid cancer cells.
Data Highlights
The original version of this article has been updated to correct an oversight in Figure 1.
Key Findings
The correction pertains to an image of TPC-1 in Figure 1B.
TSHR signaling and PTEN/PI3K pathways are implicated in thyroid cancer cell dedifferentiation.
Previous studies have linked abnormal signaling pathways to cancer progression.
Clinical Implications
Clinicians should be aware of the importance of accurate data representation in research publications. Understanding the role of TSHR and PTEN/PI3K pathways may inform future therapeutic strategies for thyroid cancer.
Conclusion
This erratum highlights the necessity for precision in scientific communication, particularly in the context of cancer research.
